SCHEMBL14929936

SCHEMBL14929936

NC(=O)c1cc(Cl)c(NC2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 18/20 0.75
▸ KCNH2 Q12809 4/20 0.75
▸ FER P16591 1/20 0.73
▸ JAK2 O60674 2/20 0.73
▸ FLT3 P36888 2/20 0.73
▸ LCK P06239 1/20 0.73
▸ YES1 P07947 1/20 0.73
▸ LYN P07948 1/20 0.73
▸ FGR P09769 1/20 0.73
▸ SRC P12931 1/20 0.73
▸ PRKCA P17252 1/20 0.73
▸ ZAP70 P43403 1/20 0.73
▸ MAP3K9 P80192 1/20 0.73
▸ PAK5 Q9P286 1/20 0.73
▸ ROCK2 O75116 1/20 0.57
▸ MAP4K4 O95819 1/20 0.57
▸ HCK P08631 1/20 0.57
▸ ROS1 P08922 1/20 0.57
▸ PIM1 P11309 1/20 0.57
▸ PRKACA P17612 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14931173 1.00 SYK (0.75) SYKKCNH2FERJAK2FLT3
SCHEMBL5026431 0.93 SYK (0.80) SYKKCNH2FERJAK2FLT3
SCHEMBL14908938 0.90 SYK (0.75) SYKKCNH2FERJAK2FLT3
SCHEMBL9110112 0.90 SYK (0.75) SYKKCNH2FERJAK2FLT3
SCHEMBL14929575 0.90 SYK (0.75) SYKKCNH2FERJAK2FLT3
SCHEMBL5027032 0.87 FER (0.74) SYKKCNH2FERJAK2FLT3
SCHEMBL9106552 0.86 SYK (1.00) SYKKCNH2FERJAK2FLT3
SCHEMBL14929934 0.84 FER (1.00) SYKKCNH2FERJAK2FLT3
SCHEMBL14910186 0.84 FER (1.00) SYKKCNH2FERJAK2FLT3
SCHEMBL14910185 0.84 FER (1.00) SYKKCNH2FERJAK2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 — — US disclosed
US-8809371-B2 — — 2014-08-19 — — US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK SYK 1/4885KCNH2 1263/4885FER 919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback